ArticleQuantitative imaging in medicine and surgery2026
Application of 50-keV virtual monochromatic imaging combined with a personalized contrast agent protocol in computed tomography pulmonary angiography: a randomized controlled trial.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography pulmonary angiography (CTPA) is the preferred imaging modality for the diagnosis of pulmonary embolism (PE). Conventional fixed contrast agent protocols are associated with high contrast volume and severe superior vena cava (SVC) artifacts. This study aimed to evaluate the value of 50-keV virtual monochromatic imaging (VMI) combined with a body weight-adjusted personalized contrast agent protocol in reducing contrast load and optimizing image quality in CTPA. Methods: A total of 76 patients undergoing CTPA were randomly allocated to the control group (Group A; n=38) or the experimental group (Group B; n=38). Since this was a small-sample exploratory study on imaging technology, it was not registered on any official platform. Both groups were scanned with a tube voltage of 120-kVp and automatic tube current modulation. Patients in group A received a fixed contrast protocol (flow rate 4.0 mL/s; volume 40 mL) with 120-kVp reconstruction. Meanwhile, patients in Group B were subjected to a body weight-adjusted protocol with weights of 40-60 kg, 60-80 kg, and 80-100 kg, having a flow rate and volume of 2.3 mL/s and 13 mL, 2.6 mL/s and 15 mL, and 2.9 mL/s and 17 mL, respectively. For all weights, 50-keV VMI reconstruction was conducted. Objective and subjective image quality was compared between the groups. Results: All images were diagnostically acceptable. Group B had a significantly lower contrast dose (15.1±0.64 mL; 62.25% reduction) and flow rate (2.55±0.18 mL/s; 36.25% reduction) (both P values <0.05). Group B also demonstrated significantly higher computed tomography (CT) values in the right pulmonary artery [406.3±112.9 Conclusions: In CTPA examination, 50-keV VMI combined with a personalized contrast agent protocol can improve image quality while substantially reducing both the contrast dose and injection flow rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.